ID   GOTO.P3
AC   CVCL_2911
SY   Goto-P3; GOTO-P3; GOTO/P3
DR   CLO; CLO_0050269
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03470916
DR   BioSample; SAMN03472373
DR   cancercelllines; CVCL_2911
DR   Cosmic; 724827
DR   Cosmic; 906876
DR   IARC_TP53; 27694
DR   JCRB; JCRB0612.1
DR   JCRB; NIHS0370
DR   RCB; RCB0721
DR   Wikidata; Q54871617
RX   PubMed=12068308;
RX   PubMed=15892104;
RX   PubMed=25877200;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=12068308).
CC   Omics: Array-based CGH.
CC   Omics: Transcriptome analysis by microarray.
CC   Misspelling: GOTO?P3; BioSample=SAMN03470916; PubMed=25877200.
CC   Discontinued: JCRB; NIHS0370; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): JCRB; PubMed=25877200; RCB
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=25877200)
ST   CSF1PO: 10,12 (JCRB; RCB)
ST   D13S317: 15
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 31,32
ST   D2S1338: 22,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1234 ! GOTO
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 23
//
RX   PubMed=12068308; DOI=10.1038/nature00766;
RA   Davies H., Bignell G.R., Cox C., Stephens P.J., Edkins S., Clegg S.,
RA   Teague J.W., Woffendin H., Garnett M.J., Bottomley W., Davis N.,
RA   Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J.,
RA   Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S.,
RA   Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.S.,
RA   Shipley J.M., Hargrave D., Pritchard-Jones K., Maitland N.J.,
RA   Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A.,
RA   Flanagan A.M., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T.,
RA   Weber B.L., Seigler H.F., Darrow T.L., Paterson H.F., Marais R.,
RA   Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.;
RT   "Mutations of the BRAF gene in human cancer.";
RL   Nature 417:949-954(2002).
//
RX   PubMed=15892104; DOI=10.1002/gcc.20198;
RA   Mosse Y.P., Greshock J., Margolin A.A., Naylor T., Cole K., Khazi D.,
RA   Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L.,
RA   Maris J.M.;
RT   "High-resolution detection and mapping of genomic DNA alterations in
RT   neuroblastoma.";
RL   Genes Chromosomes Cancer 43:390-403(2005).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//